Aug. 28 at 3:00 PM
$HCTI Why the Korean bot attacks on
$HCTI?
Feels like a smear campaign. Many small-cap stocks with dilution or compliance risk get targeted by automated accounts aiming to tank sentiment. Often these bots are seeded to spread fear, uncertainty, and doubt—especially around ticker walls and compliance deadlines.
Who might benefit if HCTI fails?
Competing micro‑caps like
$CNGL,
$ASST,
$UPLD, STRM, MSPR, and others all play in the same software/healthcare-tech microspace
marketbeat.com
—they gain attention and capital if HCTI fades.
But HCTI’s real edge? Strong Q2 momentum, improving liquidity, active subs (Ezovion, QuantumNexis), a return to Nasdaq compliance, and an undervalued P/S of ~1.2× with upside into the
$4–9 range.
Ignore the noise. Focus on fundamentals, shareholders, and the story.
